In the orchiectomy patient group, 11/41 patients were hypergonadotropic, and 9/11 patients hypergonadotropic hypogonadal orchiectomy patients were biochemical non‐responders. Biochemical and clinical response of CC therapy and hypogonadal symptom improvement. In this non‐responder group, mean LH before treatment was 13.7 IU/L (range, 4.6–29), compared with a mean of 4.7 IU/L (range, 0.6–25) in the responder group. The first measurement during treatment was at a median of 1.5 months (range, 1–12). Data on patient characteristics, comorbidities and dosage at start of treatment, are provided in Table 1. In total, 173 male patients treated with CC were screened for inclusion. With the clinical knowledge in 2012 based on expert opinion at that time, men received CC, with a starting dosage of 25 mg every other day, or 25 mg a day in case of bodyweight above 100 kg.
However, it is not without risks, and some men may experience side effects such as mood swings, vision changes, or hormonal imbalances. Another key concern is what happens when Clomid treatment stops. Some men may also experience a drop in testosterone when they stop taking Clomid. There is a possibility that long-term use could make the body less responsive to the drug, meaning it may stop working over time.
Side effects are possible, but regular lab work helps keep treatment safe. Clomid, however, keeps the system active, which means sperm production is usually preserved or even improved. This chain reaction stimulates the testicles to make more testosterone and sperm naturally. To understand Clomid, it helps to first review how the body makes testosterone. Clomid, also known by its generic name clomiphene citrate, is a medicine that was first created to help women with fertility problems. Because TRT can lower or stop sperm production, it may not be the right choice for men trying to stay fertile. Age, overall health, and the reason for low testosterone all influence how well TRT works.
When used together, their combined impact on sperm production and fertility must be understood clearly. Some treatments for low testosterone can reduce fertility, while others may help preserve it. Sometimes, other medications are added to control estrogen or support sperm production. This combination can help reduce some of the side effects linked to higher TRT doses, such as shrinking testicles or reduced sperm production. The dosage depends on the person’s age, weight, blood levels, and symptoms. Clomid (clomiphene citrate) is usually prescribed off-label for men with low testosterone who want to maintain fertility. Other men may start with testosterone therapy, but find that their sperm count drops.
Clomid helps keep estrogen levels in check because it blocks estrogen receptors in the brain. Too much estrogen in men can cause side effects such as breast tenderness, water retention, or mood swings. Testosterone can change into estrogen in the body through a process called aromatization. It supports the brain’s natural signals to the testicles, which helps keep sperm production going.
In men, too much estrogen can tell the brain to slow down testosterone production. When levels drop, the brain increases production again. Monitoring helps to adjust the dose and avoid risks such as high red blood cell count, increased estrogen, or sleep apnea worsening. Each method delivers testosterone in a slightly different way, but all aim to raise blood levels back into the normal range. We will look at how they work, their effects on testosterone and fertility, their risks and benefits, and the types of men who may benefit from each approach. Clomid is not a type of testosterone but a selective estrogen receptor modulator, meaning it changes how the body senses estrogen. At first glance, they may seem like they do the same thing—help raise testosterone levels—but they actually work in very different ways.